➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Mallinckrodt
Johnson and Johnson
McKesson
AstraZeneca

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LOVASTATIN

» See Plans and Pricing

« Back to Dashboard

505(b)(2) Clinical Trials for Lovastatin

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT00092846 A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2002-12-01 The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Lovastatin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000463 Post Coronary Artery Bypass Graft (CABG) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1987-04-01 To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously.
NCT00000469 Asymptomatic Carotid Artery Plaque Study (ACAPS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1988-05-01 To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk individuals with asymptomatic carotid stenosis. Also, to determine if a full scale trial was feasible.
NCT00000477 Cholesterol Reduction in Seniors Program (CRISP) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1990-07-01 To conduct a pilot study to determine whether lowering elevated serum cholesterol levels with 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase inhibitors reduced mortality due to the sequelae of atherosclerotic cardiovascular disease in older men and women.
NCT00000512 Familial Atherosclerosis Treatment Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1984-01-01 To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography.
NCT00000512 Familial Atherosclerosis Treatment Study Completed University of Washington Phase 3 1984-01-01 To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography.
NCT00004346 Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis Unknown status Oregon Health and Science University Phase 2 1996-01-01 OBJECTIVES: I. Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of individual sterols and bile acids in patients with cerebrotendinous xanthomatosis before and after a cholesterol- and cholestanol-free diet. II. Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of individual sterols and bile acids in these patients before and after lovastatin and chenodeoxycholic acid.
NCT00004346 Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis Unknown status National Center for Research Resources (NCRR) Phase 2 1996-01-01 OBJECTIVES: I. Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of individual sterols and bile acids in patients with cerebrotendinous xanthomatosis before and after a cholesterol- and cholestanol-free diet. II. Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of individual sterols and bile acids in these patients before and after lovastatin and chenodeoxycholic acid.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lovastatin

Condition Name

Condition Name for Lovastatin
Intervention Trials
Hypercholesterolemia 6
Cardiovascular Diseases 5
Heart Diseases 4
Dyslipidemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lovastatin
Intervention Trials
Hypercholesterolemia 8
Cardiovascular Diseases 7
Syndrome 5
Myocardial Ischemia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lovastatin

Trials by Country

Trials by Country for Lovastatin
Location Trials
United States 116
Canada 11
Taiwan 7
Korea, Republic of 3
Germany 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lovastatin
Location Trials
California 15
Pennsylvania 6
New York 6
Utah 5
North Carolina 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lovastatin

Clinical Trial Phase

Clinical Trial Phase for Lovastatin
Clinical Trial Phase Trials
Phase 4 10
Phase 3 10
Phase 2/Phase 3 2
[disabled in preview] 40
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lovastatin
Clinical Trial Phase Trials
Completed 39
Recruiting 11
Not yet recruiting 5
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lovastatin

Sponsor Name

Sponsor Name for Lovastatin
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 5
National Taiwan University Hospital 4
National Science Council, Taiwan 3
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lovastatin
Sponsor Trials
Other 75
Industry 23
NIH 14
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Mallinckrodt
Medtronic
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.